PhotoCure

Companies PhotoCure

News PhotoCure

• Photocure appoints Chief Financial Officer

  Photocure ASA announced the appointment of Erik Dahl to its management team as the Chief Financial Officer, effective 15 August 2012.Dahl joins Photocure with more than 20 years of experience in senior level financial management roles in both international public and private companies. He has a stro more

• Photocure announces positive results of Phase 2B study evaluating Visonac in acne

  Photocure ASA announced the results of the phase 2b study in acne with Visonac (methyl aminolevulinate 80mg/g), a topical acne treatment.  In this study, Visonac showed a statistically significant reduction in inflammatory lesions and overall improvement in acne severity.The phase 2b trial was a mul more

• Photocure announces the achievement of the second transition milestone of EUR 1.5 million for Hexvix

  Photocure ASA announced the achievement of the second manufacturing transition milestone from Ipsen, its new strategic partner for commercializing Hexvix worldwide, excluding the US and Nordic region. This triggers a payment of EUR 1.5 million. Hexvix is Photocure’s flagship product to aid in diagno more

Publications PhotoCure

• Biphenyl liquid crystalline epoxy resin as a low-shrinkage resin-based dental restorative nanocomposite

  Low-shrinkage resin-based photocurable liquid crystalline epoxy nanocomposite has been investigated with regard to its application as a dental restoration material. The nanocomposite consists of an organic matrix and an inorganic reinforcing filler. The organic matrix is made of liquid crystalline more

• Cell attachment and response to photo – cured, degradable bone adhesives containing tricalcium phosphate and purmorphamine

  The study aim was to quantify and provide evidence as to how addition of β-TCP and the hedgehog agonist purmorphamine to a degradable bone adhesive affects cell attachment / proliferation and hedgehog pathway activation. FTIR demonstrated high levels (75 wt%) of tricalcium phosphate (β-TCP) addition more

Market studies PhotoCure

• PCI Biotech AS (PCIB) - Strategic SWOT Analysis Review

  PCI Biotech AS (PCI Biotech) is a drug delivery company, engaged in commercialization of photochemical drug delivery technology for therapeutic treatments such as gene therapy, protein therapy, oligonucleotide therapy, chemotherapy and nanomedicine. PCI Biotech operates as a subsidiary of the Norweg more

Websites PhotoCure